Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.
AUTOR(ES)
Palacios, G C
RESUMO
The low incidence of group B streptococcal (GBS) invasive neonatal disease in Mexico has been attributed to the low prevalence of serotype III strains, a major serotype in developed countries. In addition, nontypeable strains account for 12% of the isolates in Mexico and < 1% of the isolates in the United States. In this study, 57 GBS isolates (28 nontypeable by the Lancefield procedure) from carrier and infected neonates and women from Mexico were also examined for the presence of type-specific antigen by an enzymatic procedure using N-acetylmuramidase digestion of the cell wall to release soluble type-specific antigen. Of the 28 nontypeable strains from Mexico, 23 were typeable by the enzyme extraction procedure, with serotype III being the predominant serotype in invasive disease. These results suggest that nontypeable isolates of GBS should be further examined by the enzymatic extraction procedure to determine the presence of type-specific antigen. Furthermore, these limited results suggest that serotype III is likely a major serotype in invasive disease also in Mexico.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=230088Documentos Relacionados
- Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.
- Streptococcal group B type antigen X in group L streptococci.
- Type-Specific Antigens of Group B Type Ic Streptococci
- Type-Specific Antigens of Group B Type Ic Streptococci
- High Expression of a C Protein β Antigen Gene among Invasive Strains from Certain Clonally Related Groups of Type Ia and Ib Group B Streptococci